MYELOMA

This study is testing a new cell therapy for multiple myeloma that has come back or stopped responding to standard treatments. Doctors are giving patients immune cells (NK cells) from donated umbilical cord blood that have been genetically modified to better find and attack the c…

This study is testing whether a combination of three drugs (elotuzumab, iberdomide, and dexamethasone) can help control multiple myeloma in patients whose cancer has returned or stopped responding to many treatments, including a recent CAR-T cell therapy. The goal is to see if th…

This study is testing whether stopping regular immunoglobulin therapy (with or without preventive antibiotics) works as well as continuing it to prevent serious infections in people with blood cancers like myeloma, leukemia, and lymphoma. Researchers will compare these different …

This early-phase trial is testing the safety and best dose of the drug belantamab mafodotin for people with high-risk smoldering multiple myeloma, a condition where abnormal blood cells are present but haven't yet caused major symptoms. The study will enroll 30 participants to fi…

This early-stage trial is testing a new oral medication called KTX-1001 for adults with advanced multiple myeloma that has returned or stopped responding to standard treatments. The study aims to find the safest and most effective dose and see if the drug helps control the cancer…

This study is testing whether patients with multiple myeloma can safely give themselves their standard chemotherapy injections at home instead of traveling to a hospital. Researchers want to see if home administration works well, is safe, and improves quality of life for patients…

This study tests whether adding the drug elranatamab as maintenance therapy after CAR-T cell treatment can help keep myeloma from returning in high-risk patients. It will measure how long patients live without their cancer getting worse. The trial is for people with relapsed myel…

This study is testing whether preventive antibiotics or immunoglobulin treatments work better to stop serious infections in people with blood cancers like leukemia, lymphoma, and myeloma. It will involve about 900 participants who have not yet started on immunoglobulin therapy. T…

This study aims to find the safest and most effective way to prevent serious infections in people with blood cancers like leukemia, lymphoma, and myeloma. Researchers are comparing two different prevention strategies: long-term antibiotics versus immunoglobulin replacement therap…

This trial aims to find the safest and most effective way to prevent serious infections in adults with blood cancers like myeloma, lymphoma, and leukemia. It will directly compare two common prevention strategies: immunoglobulin therapy and antibiotics. The goal is to see which a…

This study is testing a home-based recovery program for people with lymphoma or myeloma who are undergoing CAR-T cell therapy. The program uses a tablet or smartphone to guide patients through personalized exercise, nutrition, and counseling plans from home. The main goal is to s…

This study is testing a new hospice care program that provides blood transfusions at home for patients with advanced blood cancers. The goal is to see if this program improves patients' quality of life and mood, and helps more people choose hospice care, compared to the usual sta…

This study aims to create a large collection of blood samples from cancer patients and people at high risk for cancer. Researchers will use these samples to build a research library for future studies on 'liquid biopsies'—blood tests that can detect cancer DNA. The goal is to hel…

This study is testing a new type of imaging scan to see if it can find leftover cancer cells in people with leukemia or myeloma. Researchers want to know if the scan results match up with other standard lab tests. The goal is to see if this scan could one day help doctors better …

This study aims to understand how the services from the nonprofit Blood Cancer United affect people with blood cancers. Researchers will follow 400 patients for six months to see if the organization's help improves their access to medical care, quality of life, and financial stre…